Detección del receptor tipo 2 del factor de crecimiento epidérmico humano (her2/neu): inmunohistoquímica en carcinomas de mama

Quirós Alpízar, José Luis; Arce Jiménez, Isabel; Torrealba Acosta, Gabriel; Jiménez Montero, Ernesto; Barrientos Cordero, Raquel.
Acta Médica Costarricense ; 57(1): 23-28, 201503.
Artículo en Español | CCSS | ID: mcs-1800

Documentos relacionados

  1. [Supervivencia en cáncer de mama por subtipo mediante inmunohistoquímica: Un estudio retrospectivo].
  2. Breast cancer in young black women.
  3. Bacteria in tumors "hit the road" together.
  4. Deciphering breast cancer: from biology to the clinic.
  5. Tissue-resident FOLR2<sup>+</sup> macrophages associate with CD8<sup>+</sup> T cell infiltration in human breast cancer.
  6. Effect of omission of surgery on survival in patients aged 80 years and older with early-stage hormone receptor-positive breast cancer.
  7. Prognostic value of KI-67 proliferation index in luminal breast cancers.
  8. Bridging the Age Gap: a prognostic model that predicts survival and aids in primary treatment decisions for older women with oestrogen receptor-positive early breast cancer.
  9. Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.
  10. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer.